Natixis Advisors LLC grew its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 12.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,882 shares of the company's stock after buying an additional 4,067 shares during the quarter. Natixis Advisors LLC's holdings in Doximity were worth $1,916,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Shaker Investments LLC OH acquired a new position in Doximity during the fourth quarter worth about $559,000. Penserra Capital Management LLC acquired a new stake in Doximity during the 3rd quarter valued at $2,384,000. Principal Financial Group Inc. increased its position in Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock worth $15,695,000 after buying an additional 4,282 shares in the last quarter. Newbridge Financial Services Group Inc. purchased a new stake in shares of Doximity in the fourth quarter valued at $362,000. Finally, Stratos Wealth Partners LTD. purchased a new stake in Doximity during the 4th quarter worth about $203,000. Institutional investors and hedge funds own 87.19% of the company's stock.
Insider Buying and Selling
In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 37.40% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Wells Fargo & Company reiterated an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Canaccord Genuity Group lifted their target price on shares of Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research note on Friday, February 7th. Stephens started coverage on Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 price target on the stock. Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research note on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $64.22.
Get Our Latest Stock Analysis on Doximity
Doximity Trading Down 3.6 %
NASDAQ:DOCS traded down $2.15 during mid-day trading on Friday, hitting $58.40. The company had a trading volume of 2,279,418 shares, compared to its average volume of 1,944,964. The business has a fifty day simple moving average of $65.39 and a 200-day simple moving average of $54.15. The firm has a market capitalization of $10.90 billion, a price-to-earnings ratio of 58.40, a PEG ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
